Molecular investigation, using chromosomal microarray and whole exome sequencing, of six patients affected by Williams Beuren syndrome and Autism Spectrum Disorder

Julie Masson, Caroline Demily, Nicolas Chatron, Audrey Labalme, Pierre-Antoine Rollat-Farnier, Caroline Schluth-Bolard, Brigitte Gilbert-Dussardier, Fabienne Giuliano, Renaud Touraine, Sylvie Tordjman, Alain Verloes, Giuseppe Testa, Damien Sanlaville, Patrick Edery, Gaetan Lesca, Massimiliano Rossi, Julie Masson, Caroline Demily, Nicolas Chatron, Audrey Labalme, Pierre-Antoine Rollat-Farnier, Caroline Schluth-Bolard, Brigitte Gilbert-Dussardier, Fabienne Giuliano, Renaud Touraine, Sylvie Tordjman, Alain Verloes, Giuseppe Testa, Damien Sanlaville, Patrick Edery, Gaetan Lesca, Massimiliano Rossi

Abstract

Williams Beuren syndrome (WBS) is a multiple malformations/intellectual disability (ID) syndrome caused by 7q11.23 microdeletion and clinically characterized by a typical neurocognitive profile including excessive talkativeness and social disinhibition, often defined as "overfriendliness" and "hyersociability". WBS is generally considered as the polar opposite phenotype to Autism Spectrum Disorder (ASD). Surprisingly, the prevalence of ASD has been reported to be significantly higher in WBS (12%) than in general population (1%). Our study aims to investigate the molecular basis of the peculiar association of ASD and WBS. We performed chromosomal microarray analysis and whole exome sequencing in six patients presenting with WBS and ASD, in order to evaluate the possible presence of chromosomal or gene variants considered as pathogenic.Our study shows that the presence of ASD in the recruited WBS patients is due to i) neither atypically large deletions; ii) nor the presence of pathogenic variants in genes localized in the non-deleted 7q11.23 allele which would unmask recessive conditions; iii) moreover, we did not identify a second, indisputable independent genetic diagnosis, related to pathogenic Copy Number Variations or rare pathogenic exonic variants in known ID/ASD causing genes, although several variants of unknown significance were found. Finally, imprinting effect does not appear to be the only cause of autism in WBS patients, since the deletions occurred in alleles of both maternal and paternal origin.The social disinhibition observed in WBS does not follow common social norms and symptoms overlapping with ASD, such as restricted interests and repetitive behavior, can be observed in "typical" WBS patients: therefore, the terms "overfriendliness" and "hypersociability" appear to be a misleading oversimplification.The etiology of ASD in WBS is likely to be heterogeneous. Further studies on large series of patients are needed to clarify the observed variability in WBS social communication, ranging from excessive talkativeness and social disinhibition to absence of verbal language and social deficit.

Keywords: 7q11.23 microdeletion; Autism Spectrum Disorder; GTF2I; Whole exome sequencing; Williams Beuren syndrome.

Conflict of interest statement

All the authors declare no competing interests.

References

    1. Morris CA. Williams Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993. . Accessed 30 Jan 2018.
    1. Tordjman S, Anderson GM, Botbol M, Toutain A, Sarda P, Carlier M, et al. Autistic disorder in patients with Williams-Beuren syndrome: a reconsideration of the Williams-Beuren syndrome phenotype. PLoS One. 2012;7:e30778. doi: 10.1371/journal.pone.0030778.
    1. Adamo A, Atashpaz S, Germain P-L, Zanella M, D’Agostino G, Albertin V, et al. 7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages. Nat Genet. 2015;47:132–141. doi: 10.1038/ng.3169.
    1. Crespi BJ, Hurd PL. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population. BMC Neurosci. 2014;15:127. doi: 10.1186/s12868-014-0127-1.
    1. Tordjman S, Anderson GM, Cohen D, Kermarrec S, Carlier M, Touitou Y, et al. Presence of autism, hyperserotonemia, and severe expressive language impairment in Williams-Beuren syndrome. Mol Autism. 2013;4:29. doi: 10.1186/2040-2392-4-29.
    1. Richards C, Jones C, Groves L, Moss J, Oliver C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2015;2:909–916. doi: 10.1016/S2215-0366(15)00376-4.
    1. Klein-Tasman BP, van der Fluit F, Mervis CB. Autism Spectrum symptomatology in children with Williams Syndrome who have phrase speech or fluent language. J Autism Dev Disord. 2018;48:3037–3050. doi: 10.1007/s10803-018-3555-4.
    1. Fusco C, Micale L, Augello B, Teresa Pellico M, Menghini D, Alfieri P, et al. Smaller and larger deletions of the Williams Beuren syndrome region implicate genes involved in mild facial phenotype, epilepsy and autistic traits. Eur J Hum Genet. 2014;22:64–70. doi: 10.1038/ejhg.2013.101.
    1. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet med off J am Coll. Med Genet. 2015;17:405–424. doi: 10.1038/gim.2015.30.
    1. Klein-Tasman BP, Phillips KD, Lord C, Mervis CB, Gallo FJ. Overlap with the autism spectrum in young children with Williams syndrome. J Dev Behav Pediatr JDBP. 2009;30:289–299. doi: 10.1097/DBP.0b013e3181ad1f9a.
    1. Kopp ND, Parrish PCR, Lugo M, Dougherty JD, Kozel BA. Exome sequencing of 85 Williams–Beuren syndrome cases rules out coding variation as a major contributor to remaining variance in social behavior. Mol Genet Genomic Med. 2018;6:749–765. doi: 10.1002/mgg3.429.
    1. Mucha BE, Banka S, Ajeawung NF, Molidperee S, Chen GG, Koenig MK, et al. Correction: a new microdeletion syndrome involving TBC1D24, ATP6V0C, and PDPK1 causes epilepsy, microcephaly, and developmental delay. Genet Med Off J Am Coll Med Genet. 2019.
    1. Bhattacharya MRC, Geisler S, Pittman SK, Doan RA, Weihl CC, Milbrandt J, et al. TMEM184b promotes axon degeneration and neuromuscular junction maintenance. J Neurosci. 2016;36:4681–4689. doi: 10.1523/JNEUROSCI.2893-15.2016.
    1. Akiyama H, Nakadate K, Sakakibara S-I. Synaptic localization of the SUMOylation-regulating protease SENP5 in the adult mouse brain. J Comp Neurol. 2018;526:990–1005. doi: 10.1002/cne.24384.
    1. Ramos PS, Sajuthi S, Langefeld CD, Walker SJ. Immune function genes CD99L2, JARID2 and TPO show association with autism spectrum disorder. Mol Autism. 2012;3:4. doi: 10.1186/2040-2392-3-4.
    1. Mo W, Liu J, Zhang Z, Yu H, Yang A, Qu F, et al. A study of single nucleotide polymorphisms in CD157, AIM2 and JARID2 genes in Han Chinese children with autism spectrum disorder. Nord J Psychiatry. 2018;72:179–183. doi: 10.1080/08039488.2017.1410570.
    1. Lotan A, Fenckova M, Bralten J, Alttoa A, Dixson L, Williams RW, et al. Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders. Front Neurosci. 2014;8:331. doi: 10.3389/fnins.2014.00331.
    1. Castermans D, Wilquet V, Parthoens E, Huysmans C, Steyaert J, Swinnen L, et al. The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet. 2003;40:352–356. doi: 10.1136/jmg.40.5.352.
    1. Nuytens K, Gantois I, Stijnen P, Iscru E, Laeremans A, Serneels L, et al. Haploinsufficiency of the autism candidate gene Neurobeachin induces autism-like behaviors and affects cellular and molecular processes of synaptic plasticity in mice. Neurobiol Dis. 2013;51:144–151. doi: 10.1016/j.nbd.2012.11.004.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir